Literature DB >> 33342712

LoVE in a time of CoVID: Clinician and patient experience using telemedicine for chronic epilepsy management.

Jack Banks1, Derek Corrigan2, Roger Grogan3, Hany El-Naggar4, Máire White4, Elisabeth Doran5, Cara Synnott5, Mary Fitzsimons2, Norman Delanty4, Colin P Doherty6.   

Abstract

As part of our ongoing interest in patient- and family-centered care in epilepsy, we began, before the onset of the CoVID-19 pandemic, to evaluate the concerns and preferences of those delivering and receiving care via telemedicine. CoVID-19 arrived and acted as an unexpected experiment in nature, catalyzing telemedicine's widespread implementation across many disciplines of medicine. The arrival of CoVID-19 in Ireland gave us the opportunity to record these perceptions pre- and post-CoVID. Data were extracted from the National Epilepsy Electronic Patient Record (EEPR). Power BI Analytics collated data from two epilepsy centers in Dublin. Analysis of data on reasons for using the telephone support line was conducted. A subset of patients and clinicians who attended virtual encounters over both periods were asked for their perception of telemedicine care through a mixed methods survey. Between 23rd December 2019 and 23rd March 2020 (pre-CoVID era), a total of 1180 patients were seen in 1653 clinical encounters. As part of a telemedicine pilot study, 50 of these encounters were scheduled virtual telephone appointments. Twenty eight surveys were completed by clinicians and 18 by patients during that period. From 24th March 2020 to 24th June 2020, 1164 patients were seen in 1693 encounters of which 729 (63%) patients were seen in 748 scheduled virtual encounters. 118 clinician impressions were captured through an online survey and 75 patients or carers completed a telephone survey during the post-CoVID era. There was no backlog of appointments or loss of care continuity forced by the pandemic. Clinicians expressed strong levels of satisfaction, but some doubted the suitability of new patients to the service or candidates for surgery receiving care via telemedicine. Patients reported positive experiences surrounding telephone appointments comparing them favorably to face-to-face encounters. The availability of a shared EEPR demonstrated no loss of care contact for patients with epilepsy. The survey showed that telemedicine is seen as an effective and satisfactory method of delivering chronic outpatient care.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Digital Health; Electronic Patient Records; Remote Care; Telemedicine; eHealth

Year:  2020        PMID: 33342712     DOI: 10.1016/j.yebeh.2020.107675

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  5 in total

Review 1.  Telemedicine and artificial intelligence to support self-isolation of COVID-19 patients: Recent updates and challenges.

Authors:  Jessica A Huang; Intan R Hartanti; Michelle N Colin; Dian Ae Pitaloka
Journal:  Digit Health       Date:  2022-05-15

2.  Transition to Virtual Asthma Care During the COVID-19 Pandemic: An Observational Study.

Authors:  Peter J Cvietusa; Glenn K Goodrich; John F Steiner; Jo Ann Shoup; Diane K King; Debra P Ritzwoller; Susan M Shetterly; Bruce G Bender
Journal:  J Allergy Clin Immunol Pract       Date:  2022-03-06

3.  Maintaining access to HIV pre-exposure prophylaxis in a pandemic: A service evaluation of telephone-based pre-exposure prophylaxis provision.

Authors:  Lindsay Henderson; Jo Gibbs; Jacqueline Quinn; Sharmini Ramasami; Claudia Estcourt
Journal:  Int J STD AIDS       Date:  2022-04-23       Impact factor: 1.456

Review 4.  Studying both patient and staff experience to investigate their perceptions and to target key interactions to improve: a scoping review.

Authors:  Marion Crubezy; Sara Corbin; Sophie Hyvert; Philippe Michel; Julie Haesebaert
Journal:  BMJ Open       Date:  2022-10-10       Impact factor: 3.006

Review 5.  The Research on Patient Satisfaction with Remote Healthcare Prior to and during the COVID-19 Pandemic.

Authors:  Liliana Hawrysz; Grażyna Gierszewska; Agnieszka Bitkowska
Journal:  Int J Environ Res Public Health       Date:  2021-05-17       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.